This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Pfizer Corporation, Lifecore Biomedical, Inc.. Active years: 1996-2020.
Location History:
- Somerville, NJ (US) (1996)
- New York, NY (US) (2019 - 2020)
Company Filing History:
Years Active: 1996-2020
Title: W James Huang: Innovator in Pharmaceutical Formulations
Introduction
W James Huang is a notable inventor based in New York, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations for intravenous administration. With a total of 3 patents to his name, Huang's work is recognized for its potential impact on patient care.
Latest Patents
Huang's latest patents focus on formulations of a PI3K/mTOR-inhibitor for intravenous administration. The first patent describes a pharmaceutical aqueous formulation comprising 1-(4-{[4-(dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea, or a pharmaceutically acceptable salt thereof, that is a clear solution. This formulation is particularly suitable for intravenous or parenteral administration to a patient. The second patent also relates to a similar formulation, emphasizing the importance of clear solutions for effective delivery in clinical settings.
Career Highlights
Throughout his career, W James Huang has worked with prominent companies in the pharmaceutical industry. He has been associated with Pfizer Corporation and Lifecore Biomedical, Inc., where he has contributed to various innovative projects. His experience in these organizations has helped him refine his expertise in drug formulation and development.
Collaborations
Huang has collaborated with several professionals in his field, including Aidan James Harper and Kevin Richard Back. These collaborations have likely enriched his work and contributed to the success of his inventions.
Conclusion
W James Huang is a distinguished inventor whose work in pharmaceutical formulations has the potential to enhance patient treatment options. His contributions to the field are marked by his innovative patents and collaborations with industry leaders.